Filed: 11/14/2023ACC: 0001389932-23-000010
📋 What this filing means
DAFNA CAPITAL MANAGEMENT LLC filed this quarterly 13F‑HR report disclosing 75 equity positions with a total reported market value of $321.49M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
75
Positions
$321.49M
Total AUM (reported)
45.16M
Total Shares
Allocation by class
COM$187.93M58.5%
ETF$53.79M16.7%
COM NEW$41.38M12.9%
SPONSORED ADR$12.75M4.0%
COMMON STOCK$6.41M2.0%
SPONSORED ADS$5.63M1.8%
NOTE 2.250% 4/0$3.69M1.1%
Portfolio Concentration
Top 3$77.00M24.0%
4–10$85.43M26.6%
11–25$87.04M27.1%
Rest$72.02M22.4%
Top 3 weight
24.0%
Top 10 weight
50.5%
Voting Authority Distribution
Total shares with voting rights: 45.16M
Sole
Full voting authority
45.16M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole75
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings75
Rows:
SPDR S&P BIOTECH ETF
SOLEShares565K
TypeSH
Market value$41.26M
12.83%
Sole
565K
Shared
0.00
None
0.00
STEREOTAXIS INC
SOLEShares13.68M
TypeSH
Market value$21.62M
6.72%
Sole
13.68M
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares479.54K
TypeSH
Market value$14.13M
4.39%
Sole
479.54K
Shared
0.00
None
0.00
IDEAYA BIOSCIENCES INC
SOLEShares499.82K
TypeSH
Market value$13.49M
4.19%
Sole
499.82K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares473.39K
TypeSH
Market value$13.10M
4.08%
Sole
473.39K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares136.21K
TypeSH
Market value$12.75M
3.97%
Sole
136.21K
Shared
0.00
None
0.00
ISHARES NASDAQ BIOTECH INDX
SOLEShares102.50K
TypeSH
Market value$12.53M
3.90%
Sole
102.50K
Shared
0.00
None
0.00
BLUEPRINT MEDICINES CORP
SOLEShares249.52K
TypeSH
Market value$12.53M
3.90%
Sole
249.52K
Shared
0.00
None
0.00
MERUS N V
SOLEShares484.87K
TypeSH
Market value$11.43M
3.56%
Sole
484.87K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares280.54K
TypeSH
Market value$9.58M
2.98%
Sole
280.54K
Shared
0.00
None
0.00
KARUNA THERAPEUTICS INC
SOLEShares52.87K
TypeSH
Market value$8.94M
2.78%
Sole
52.87K
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares73.61K
TypeSH
Market value$8.28M
2.58%
Sole
73.61K
Shared
0.00
None
0.00
DAY ONE BIOPHARMACEUTICALS I
SOLEShares586.46K
TypeSH
Market value$7.20M
2.24%
Sole
586.46K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares458.37K
TypeSH
Market value$6.66M
2.07%
Sole
458.37K
Shared
0.00
None
0.00
DEXCOM INC
SOLEShares67.55K
TypeSH
Market value$6.30M
1.96%
Sole
67.55K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares605.53K
TypeSH
Market value$5.83M
1.81%
Sole
605.53K
Shared
0.00
None
0.00
2SEVENTY BIO INC
SOLEShares1.45M
TypeSH
Market value$5.67M
1.76%
Sole
1.45M
Shared
0.00
None
0.00
ATRICURE INC
SOLEShares125.53K
TypeSH
Market value$5.50M
1.71%
Sole
125.53K
Shared
0.00
None
0.00
MORPHIC HOLDING INC
SOLEShares231.75K
TypeSH
Market value$5.31M
1.65%
Sole
231.75K
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares550.78K
TypeSH
Market value$5.02M
1.56%
Sole
550.78K
Shared
0.00
None
0.00
AXOGEN INC
SOLEShares935.89K
TypeSH
Market value$4.68M
1.46%
Sole
935.89K
Shared
0.00
None
0.00
BIOCRYST PHARMACEUTICALS INC
SOLEShares652K
TypeSH
Market value$4.62M
1.44%
Sole
652K
Shared
0.00
None
0.00
TANDEM DIABETES CARE INC
SOLEShares220.71K
TypeSH
Market value$4.58M
1.43%
Sole
220.71K
Shared
0.00
None
0.00
NURIX THERAPEUTICS INC
SOLEShares556.70K
TypeSH
Market value$4.38M
1.36%
Sole
556.70K
Shared
0.00
None
0.00
ALECTOR INC
SOLEShares628.94K
TypeSH
Market value$4.08M
1.27%
Sole
628.94K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR S&P BIOTECH ETFSOLE | ETF | 565K | SH | $41.26M 12.83% | 565K | 0.00 | 0.00 |
STEREOTAXIS INCSOLE | COM NEW | 13.68M | SH | $21.62M 6.72% | 13.68M | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 479.54K | SH | $14.13M 4.39% | 479.54K | 0.00 | 0.00 |
IDEAYA BIOSCIENCES INCSOLE | COM | 499.82K | SH | $13.49M 4.19% | 499.82K | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 473.39K | SH | $13.10M 4.08% | 473.39K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 136.21K | SH | $12.75M 3.97% | 136.21K | 0.00 | 0.00 |
ISHARES NASDAQ BIOTECH INDXSOLE | ETF | 102.50K | SH | $12.53M 3.90% | 102.50K | 0.00 | 0.00 |
BLUEPRINT MEDICINES CORPSOLE | COM | 249.52K | SH | $12.53M 3.90% | 249.52K | 0.00 | 0.00 |
MERUS N VSOLE | COM | 484.87K | SH | $11.43M 3.56% | 484.87K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 280.54K | SH | $9.58M 2.98% | 280.54K | 0.00 | 0.00 |
KARUNA THERAPEUTICS INCSOLE | COM | 52.87K | SH | $8.94M 2.78% | 52.87K | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 73.61K | SH | $8.28M 2.58% | 73.61K | 0.00 | 0.00 |
DAY ONE BIOPHARMACEUTICALS ISOLE | COM | 586.46K | SH | $7.20M 2.24% | 586.46K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 458.37K | SH | $6.66M 2.07% | 458.37K | 0.00 | 0.00 |
DEXCOM INCSOLE | COM | 67.55K | SH | $6.30M 1.96% | 67.55K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 605.53K | SH | $5.83M 1.81% | 605.53K | 0.00 | 0.00 |
2SEVENTY BIO INCSOLE | COMMON STOCK | 1.45M | SH | $5.67M 1.76% | 1.45M | 0.00 | 0.00 |
ATRICURE INCSOLE | COM | 125.53K | SH | $5.50M 1.71% | 125.53K | 0.00 | 0.00 |
MORPHIC HOLDING INCSOLE | COM | 231.75K | SH | $5.31M 1.65% | 231.75K | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COM | 550.78K | SH | $5.02M 1.56% | 550.78K | 0.00 | 0.00 |
AXOGEN INCSOLE | COM | 935.89K | SH | $4.68M 1.46% | 935.89K | 0.00 | 0.00 |
BIOCRYST PHARMACEUTICALS INCSOLE | COM | 652K | SH | $4.62M 1.44% | 652K | 0.00 | 0.00 |
TANDEM DIABETES CARE INCSOLE | COM NEW | 220.71K | SH | $4.58M 1.43% | 220.71K | 0.00 | 0.00 |
NURIX THERAPEUTICS INCSOLE | COM | 556.70K | SH | $4.38M 1.36% | 556.70K | 0.00 | 0.00 |
ALECTOR INCSOLE | COM | 628.94K | SH | $4.08M 1.27% | 628.94K | 0.00 | 0.00 |
Page 1 of 3